Regulation of cytosolic PlA2 activity by PP1/PP2A serine/threonine phosphatases in human platelets.
Autors de IIS La Fe
Abstract
Platelet thromboxane A2 (TXA2) synthesis is an important pathway of platelet reactivity. We report that in thrombin-stimulated platelets, PP1/PP2A serine/threonine phosphatases regulate phospholipase A2 (cPLA2) activity, which is required for TXA2 synthesis. Two mechanisms are involved: (a) constitutively active PP1/PP2A regulate cPLA2 phosphorylation, and (b) PP1/PP2A activity mediates agonist-induced increase in cytosolic Ca2+ ([Ca2+]i). Inhibition of PP1/PP2A with okadaic acid (OA) induces cPLA2 phosphorylation but reduces Ca2+ responses: release from intracellular stores and influx through the plasma membrane, particularly that mediated by store-mediated Ca2+ entry (SMCE). A significant correlation (r = 0.64) exists between OA-regulated [Ca2+]i and TXA2 synthesis. Okadaic acid-induced decrease in SMCE and the associated TXA2 synthesis are mediated by a reduction in protein-tyrosine phosphorylation. This reduction is not due to inhibition of tyrosine kinases but rather to an OA-mediated increase in tyrosine phosphatases. This is the first study to report that PP1/PP2A phosphatases are involved in the regulation of the two key elements in eicosanoid synthesis, [Ca2+]i and cPLA2 phosphorylation. Moreover, PP1/PP2A regulation of [Ca2+]i and tyrosine phosphorylation may be important for other calcium-dependent processes and/or signal transduction mechanisms in platelets.
Dades de la publicació
- ISSN/ISSNe:
- 0953-7104, 1369-1635
- Tipus:
- Article
- Pàgines:
- 405-415
- PubMed:
- 16973502
- Factor d'Impacte:
- 0,499 SCImago ℠
- Quartil:
- Q2 SCImago ℠
Platelets TAYLOR & FRANCIS INC
Cites Rebudes en Web of Science: 14
Documents
- No hi ha documents
Filiacions
Projectes associats
INVESTIGACION EN RED DE LAS ENFERMEDADES NEUROLOGICAS
Investigador Principal: JUAN JESÚS VÍLCHEZ PADILLA
C03/06 . INSTITUTO DE SALUD CARLOS III . 2003
AVANCES EN EL ESTUDIO DE LA REACTIVIDAD PLAQUETARIA Y SU INTERACCION CON LOS ERITROCITOS: BASES MOLECUALRES Y APLICABILIDAD CLINICO-FARMACOLOGICA
Investigador Principal: JUANA VALLES GINER
PI03/0270 . INSTITUTO DE SALUD CARLOS III . 2004
RED INVESTIGACION (RECAVA)
RD06/0014/0004 . INSTITUTO DE SALUD CARLOS III; FUNDACION PARA LA INV BIOMEDICA- HOSPITAL GREGORIO MARAÑON; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2006
RED DE INVESTIGACION (RENEVAS)
Investigador Principal: ENRIQUE ALBORCH DOMÍNGUEZ
RD06/0026/0006 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN INSTITUTO DE INVESTIGACIÓN SANITARIA DE SANTIAGO DE COMPOSTELA (FIDIS); FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2006